• GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

  • Jun 20 2024
  • Duración: 21 m
  • Podcast

GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri Por arte de portada

GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Welcome to another insightful episode of the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Toni Choueiri, a GU Medical Oncologist from Dana-Farber Cancer Institute, to discuss key abstracts from ASCO 2024.

    They delve into topics such as the impact of the EV302 study on metastatic bladder cancer, the potential role of ctDNA as a biomarker in bladder cancer, real-world data on metastatic RCC, and the PSMA-4 study in prostate cancer. The discussion covers patient-reported outcomes, treatment strategies, and the evolving landscape of oncology care.

    Tune in to gain valuable insights into the latest advancements in oncology and how they are shaping the standard of care for patients. Don't miss out on this engaging conversation with experts in the field. Subscribe to the Oncology Brothers podcast for more updates from the world of oncology.


    Website: http://www.oncbrothers.com/

    Twitter: https://twitter.com/oncbrothers

    Contact us at info@oncbrothers.com
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles